People often turn to their physician to help them lose weight because it is so difficult. Americans spend billions of dollars every year attempting to lose weight, but their efforts are largely unsuccessful. Some doctors suggest the most natural and difficult path to weight loss, which is to reduce the whole of calories consumed and ramp up rehearsal - and I talk about this formula later on in the chapter. However, many patients have tried diets, and want something a bit more great to curb their appetite so they eat less, or something that will help them curb cravings and a psychological obsession with food. And these population will keep going to doctors until they find one willing to write a prescribe for a diet drug - usually population do not have to quest for such a physician for very long. Alternatively, they will pick up some Ma Huang or an additional one dietary supplement at the drug store, lured by the promise of near magical weight loss.
However, diet drugs commonly have not been shown to help population reach or support their weight loss goal. Long-term use of diet drugs is linked with some dangers, most importantly the risk of heart attack or other cardiovascular event (even in young people). an additional one worrisome consequence of diet pills is former pulmonary hypertension (Pph), a disorder that is typically of unknown cause that is linked with an growth in the pressure of the arteries in the lungs. The former manifestation of Pph is breathing problems with exercise. The end ensue of Pph in the absence of a lung transplant is usually death. There is a 6-fold growth in risk of Pph with diet pills, including dexfenfluramine, fenfluramine, diethylpropion, clobenzorek, fenproporek, and phemetrazine. Outpatient taking diet pills for more than 3 months face a 23-fold increased risk. Although Pph is rare, so that the absolute risk of developing this disorder remains small, the unavoidable lethality of it when it occurs should be cause for concern. At this point we can say that any diet pill that admittedly affects appetite (i.e. Those affecting sympathetic function) should be carefully risky.
There are other life threatening side effects with diet pills, notably the hazardous effects of "fen-phen" (fenfluramine-phentermine) on the heart. Although the composition of these pills was never stylish by the Fda, by 1996 over 18 million prescriptions a year were being written for this composition of pills as a weight loss treatment. Ultrasound examinations of the heart showed abnormalities of the heart valves in 24 women, five of whom required cardiac surgery for valve repair. This discovery led to the retirement of fen-phen from the market.
One of the most commonly prescribed medications for obesity, sibutramine (Meridia), acts on receptors in the brain that take up the neurotransmitters dopamine, norepinephrine, and serotonin back into the neuron. These neurotransmitters are involved in mood as well as appetite regulation. By blocking the reuptake of these neurotransmitters into the neuron, they growth the whole of neurotransmitter that is ready in the space between the neurons (the synapse) and therefore growth the effects of these neurotransmitters. It is by this ensue that Meridia is felt to have its weight loss properties, although the exact mechanism is not thoroughly understood.
Meridia leads to a 4.45 kg (9 lb.) weight loss after 12 months of rehabilitation (Li et al 2005). Some studies showed up to a 10 kg (22 lb) weight loss with Meridia (Godoy-Matos et al 2005). Unfortunately, weight returns to pre-treatment levels once Meridia is discontinued. Also, multiple studies have not shown evidence that Meridia (or any other weight loss drug for that matter) reduces obesity linked death or disease, like heart disease, stroke, and hypertension.
The most common side ensue of the drug is palpitations but it also causes increased blood pressure and stroke. Forty-nine cardiac deaths linked to Meridia have been reported to the Fda. Administration to pregnant women can lead to fetal abnormalities. This has led to calls for Meridia to be removed from the market.
Orlistat (Xenical) is an additional one drug stylish for the rehabilitation of obesity. Orlistat inhibits the lipase enzyme, preventing digestion and absorption of some fats. Orlistat rehabilitation results in 6 pound weight loss that persists for as long as rehabilitation continues (Torgerson et al 2004). 91% of patients get gastrointestinal side effects, versus 65% on placebo. Diarrhea is very common, with less commonly flatulence, bloating, and dyspepsia. Orlistat inhibits absorption of fat-soluble vitamins (A, D, E, K), and may lead to vitamin deficiency, so you should take a vitamin if you are on this drug. Recently a low dose version of orlistat called Alli (pronounced like "ally") has been stylish for over the counter use in conjunction with a diet and rehearsal program.
The bottom line is that diet pills have not been shown to ensue in sustainable weight loss, and they have necessary risks which could be fatal. Therefore I do not suggest their use. The best plan is a sustained change in diet and exercise.
Godoy-Matos A, Carraro L, Vieira A, et al (2005): rehabilitation of obese adolescents with sibutramine: A randomized, double-blind, controlled study. Journal of Clinical Endocrinology & Metabolism 90:1460-1465.
Li Z, Maglione M, Tu W, et al (2005): Meta-analysis: Pharmacological rehabilitation of obesity. Annals of Internal rehabilitation 142:532-546.
Torgerson Js, Hauptman J, Boldrin Mn, Sjostrom L (2004): Xenical in the arresting of diabetes in obese subjects (Xendos) study: A randomized study of orlistat as an adjunct to lifestyle changes for the arresting of type 2 diabetes in obese patients. Diabetes Care 27:155-161.
